【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Dementia
06.2 Epidemiology & Forecast (2013-2018)
06.3 Types of Dementia
07. Alzheimer’s Disease
07.1 A Global Burden
07.2 Etiology
07.3 Cost of Care
07.4 Alzheimer’s Disease & Caregiving
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by MOA
09.1.1 AChE Inhibitors
09.1.2 Glutamate Inhibitors
10. Market Assessment of Top Drugs
10.1 Aricept
10.1.1 Sales
10.1.2 Key Regulatory Approvals and Agreements
10.1.3 US Spending by Various Channels 2010-2013
10.2 Exelon
10.2.1 Sales
10.2.2 Key Regulatory Approvals and Agreements
10.2.3 US Spending by Various Channels 2010-2013
10.3 Namenda
10.3.1 Sales
10.3.2 Key Regulatory Approvals and Agreements
10.3.3 US Spending by Various Channels 2010-2013
10.4 Radazyne
10.4.1 Sales
10.4.2 Key Regulatory Approvals and Agreements
11. Competitive Assessment of Top Drugs
12. Focus on Alzheimer’s Research
12.1 National Alzheimer’s Project Act
12.2 Clinical Pipeline
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.2 Market Share Analysis 2013
22. Future Vendors Expected To Tap the Market
23. Key Vendor Analysis
23.1 Eisai Co., Ltd.
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Sales by Geography
23.1.4 Revenue Comparison
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 Forest Laboratories Inc.
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business/Product Segmentation
23.2.4 Product Segmentation by Revenue 2013
23.2.5 Business/Products Segmentation by Revenue 2012 and 2013
23.2.6 Sales by Geography
23.2.7 Business Strategy
23.2.8 Key Information
23.2.9 SWOT Analysis
23.2.10 Strengths
23.2.11 Weaknesses
23.2.12 Opportunities
23.2.13 Threats
23.3 Janssen Pharmaceuticals Inc.
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Business Strategy
23.3.5 Key Information
23.3.6 SWOT Analysis
23.3.7 Strengths
23.3.8 Weaknesses
23.3.9 Opportunities
23.3.10 Threats
23.4 Novartis AG
23.4.1 Key Facts
23.4.2 Business Description
23.4.3 Business Segmentation
23.4.4 Revenue by Business Segmentation
23.4.5 Revenue Comparison 2012 and 2013
23.4.6 Sales by Geography
23.4.7 Business Strategy
23.4.8 Key Developments
23.4.9 SWOT Analysis
23.4.10 Strengths
23.4.11 Weaknesses
23.4.12 Opportunities
23.4.13 Threats
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Projected Prevalence of Dementia by Regions 2013-2050 (in millions)
Exhibit 3: Projected Prevalence of Dementia by Regions 2013-2018 (in millions)
Exhibit 4: Types of Dementia by Prevalence 2013
Exhibit 5: Alzheimer’s Disease and Other Dementias Burden by Geographical Segmentation (Annually) 2013
Exhibit 6: Costs of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias 2013
Exhibit 7: Distribution of Alzheimer’s Caregivers by Age, 2013
Exhibit 8: Projected Prevalence of dependence in 2030 (in percent)
Exhibit 9: Global Alzheimer’s Disease Drugs Market 2013-2018 (US$ billion)
Exhibit 10: Global Alzheimer’s Drugs Market Segmentation by MOA
Exhibit 11: Eisai Co. Ltd.’s Aricept Revenue FY1996-FY2013 (US$ million)
Exhibit 12: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY1996-FY2010 (US$ million)
Exhibit 13: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY2011-FY2013 (US$ million)
Exhibit 14: Key Event Timeline of Aricept Formulations
Exhibit 15: Timeline for Aricept Formulations in US and Europe
Exhibit 16: US Spending on Aricept by Various Channels 2010-2013
Exhibit 17: Novartis AG’s Exelon Revenue 2001-2013 (US$ million)
Exhibit 18: Novartis AG’s Exelon Geography-Wise Revenue 2001-2013 (US$ million)
Exhibit 19: Key Event Timeline of Exelon Formulations
Exhibit 20: US Spending on Exelon by Various Channels 2010-2013
Exhibit 21: Forest’s Namenda Revenue 2004-2014 (FY ending March 2014) (US$ million)
Exhibit 22: Key Event Timeline of Namenda Formulations
Exhibit 23: US Spending on Namenda by Various Channels 2010-2013
Exhibit 24: Razadyne Revenue 2007-2009 (US$ million)
Exhibit 25: Key Event Timeline of Razadyne
Exhibit 26: Sales of Top 3 Alzheimer’s Drugs FY 2004-2013 (US$ million)
Exhibit 27: Sales of Top 3 Alzheimer’s Drugs 2004-2013 (US$ million)
Exhibit 28: Alzheimer’s Disease Research Projects by NIH Institutes and Centers 2011
Exhibit 29: NIH funded Alzheimer’s Disease Research Projects by CADRO topic 2011
Exhibit 30: Classification of Disease Modifying Pipeline Molecules by MOA
Exhibit 31: Clinical Trials of Alzheimer’s Disease by Phase 2013
Exhibit 32: Clinical Trials of Alzheimer’s Disease by Recruitment Status 2013
Exhibit 33: Promising Late Stage Pipeline Molecules 2013
Exhibit 34: Global Alzheimer’s Drugs market by Geographical Segmentation 2013
Exhibit 35: 65+ Global Population 2014-2018 (in million)
Exhibit 36: Global Alzheimer’s Drugs Market Share Analysis 2013
Exhibit 37: Eisai Co., Ltd.: Geographical Segmentation of Revenue for 2013 and 2012(US$ billion)
Exhibit 38: Eisai Co., Ltd.: Revenue comparison for the last 3 years (US$ billion)
Exhibit 39: Eisai Co., Ltd.: Sales by Geography for 2013 (US$ billion)
Exhibit 40: Forest Laboratories Inc.: Product Segmentation (by therapeutic areas) 2013
Exhibit 41: Forest Laboratories Inc.: Product Segmentation by Revenue 2013
Exhibit 42: Forest Laboratories Inc.: Product Segmentation by Revenue 2012 and 2013(US$ million)
Exhibit 43: Company Name: Sales by Geography 2013
Exhibit 44: Janssen Pharmaceuticals, Inc.: Product Segmentation 2013
Exhibit 45: Novartis AG: Business Segmentation
Exhibit 46: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 47: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 48: Novartis AG: Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：アルツハイマー治療薬のグローバル市場（2014-2018）■ 英文：Global Alzheimer's Drugs Market 2014-2018
■ 発行日：2014年6月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR3675
■ 調査対象地域：グローバル
- パイプライン・ピギング装置の世界市場2017-2021About Pipeline Pigging Systems The augmented oil and gas demands need significant support from the associated infrastructure for the market to develop. In this respect, the global pipeline infrastructure has expanded by a factor of almost 100 in the past half a century. The pipelines associated in the oil and gas business are utilized to transport a multitude of commodities over various distances. …
- 自動車用プラスチックの世界市場分析：製品別（ABS、PP、PU、PVC、PE、PC、PMMA、PA）、用途別（吸収、減衰）、エンドユーザー別（パワートレイン、電気部品、内装、外装、シャーシ）、セグメント予測、2014-2025The global automotive plastics market is expected to reach USD 68.5 billion by 2025, according to a new report by Grand View Research, Inc. The shift in trend towards high performance plastics to substitute conventional metals & rubber is expected to drive demand. The quality of plastics is highly dependent upon their properties, functions and applications. Superior properties such as light weight …
- Tardive Dyskinesia：グローバル臨床試験レビューH1, 2013Tardive Dyskinesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tardive Dyskinesia Global Clinical Trials Review, H1, 2013" provides data on the Tardive Dyskinesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tardive Dyskinesia. It includes an overview of the trial numbers and their recruitme …
- がん分子診断の世界市場：乳がん、大腸がん、前立腺がんAbout oncology molecular diagnostics Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing. Oncology molecular diagnostics is a major application of …
- Enel S.p.A.：石油・ガスバリューチェーン分析レポート2013Enel S.p.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Enel S.p.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Enel S.p.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
- マルチタスキング工作機械の世界市場2017-2021About Multi-tasking Machine Tools Multi-tasking machine tools integrate the functions of both turning and machining. This eliminates the need for multiple machines to perform these functions. The typical structure of such machine includes 5 axes: three standard axes X, Y, and Z, the turning spindle of rotary C axis and another rotary axis B, around the Y axis. Technavio’s analysts forecast the glo …
- 世界のタフティング機市場2015is a professional and depth research report on Global Tufting Machine industry. For overview analysis, the report introduces Tufting Machine basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Tufting Machine markets in China and ot …
- 世界の電気抵抗溶接管市場2015The Global Electric Resistance Welded Pipes Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Electric Resistance Welded Pipes industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Electric Resistance Welded Pipes market analysis is provided for the int …
- グローバルにおける電力ケーブル市場（2014-2018）About Power Cables A power cable is an insulated strand of wires that is used to transmit electricity at variable voltage levels. Power cables are mainly used in overhead lines, buildings, and underground wiring applications to transmit electricity. Power cables are available in different sizes and shapes according to the requirements of the Telecommunication, Electrical Equipment, Construction, a …
- 世界の食品のカプセル化市場動向及び予測（～2018）The primary factor driving the growth of the food encapsulation market is the rise in demand for functional foods which offer intended health benefits. This report estimates the market size of the food encapsulation market in terms of value. Bakery & confectionery, dairy & frozen desserts, convenience foods, functional foods, beverages, and meat, poultry & seafood are the key applications for enca …
- 対話型システムの世界市場予測・分析2020-2024Global Conversational Systems Market: About this market Technavio’s conversational systems market analysis considers sales from both text and voice types. Our study also finds the sales of conversational systems in APAC, Europe, MEA, North America, and South America. In 2018, the text segment had a significant market share, and this trend is expected to continue over the forecast period. Factors s …
- 原子力発電のプラント寿命延長(Plex)市場2015：グローバル市場規模、競争状況、主要国分析Plant Life Extension (Plex) for Nuclear Power, Update 2015 - Global Market Size, Competitive Landscape and Key Country Analysis to 2025 Summary “Plant Life Extension (Plex) for Nuclear Power, Update 2015 - Global Market Size, Competitive Landscape and Key Country Analysis to 2025”, the latest report from industry analysis specialist GlobalData, offers comprehensive information and analysis of the …
- 放射線検知材料市場2013This report identifies the latest opportunities for radiation detection materials and especially those that have emerged since NanoMarkets groundbreaking report on this topic in 2011. While the materials discussed in this report are similar to those that NanoMarkets covered in the previous report, this report analyzes the commercial significance of the latest improvements in the materials covered. …
- 民間航空機PMA部品の世界市場2015-2019About commercial aircraft PMA An aircraft PMA is an approved replacement for the original part provided by an OEM, conforming to the FAA design and produced under the FAA approved production process. Since the 1950s, the FAA has been granting PMA to third-party manufacturers to produce replacement parts for aircraft. Without PMA, aircraft parts would be exclusively designed and manufactured by OEM …
- 仮想現実（VR）の世界市場：仮想現実技術、デバイス、構成要素、用途、地域別分析The virtual reality technology is a three-dimensional artificial environment, where the user can experience and interact with the virtual world. This technology is used in various applications such as gaming, entertainment, and for simulation and training purposes in aerospace, defense, medical, industrial, retail and marketing, and education applications. The market for virtual reality technology …
